Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nachiket Joshi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Molecular Diversity|January 24, 2024
Sulfonamido, amido heterocyclic adducts of tetrazole derivatives as BACE1 inhibitors: in silico explorationNachiket Joshi, Rajasekhar Reddy Alavala
Computational Biology and Chemistry|April 29, 2025
Identification of novel ligands against GSK-3β: Molecular docking, ADMET filtering, MD simulations, MM-GBSA studies, and DFT analysisNachiket Joshi, RajaSekhar Reddy Alavala
Chemistry & Biodiversity|January 24, 2025
Acetohydroxyacid Synthase (AHAS) Inhibitors as Antitubercular Agents: Insights From Molecular Docking and Dynamics SimulationsKunal Gokhale, Nachiket Joshi, RajaSekhar Reddy Alavala
Chirurgia (Bucharest, Romania : 1990)|May 25, 2026
Laparoscopic Surgery: Patient Benefits and Surgeon Challenges. A Systematic Literature Review and Narrative SynthesisAaliyah Abimbola, Gabriella Quiney, Nachiket Joshi, et al.
Current Topics in Medicinal Chemistry|June 18, 2025
Histone Deacetylase Inhibition in Alzheimer's Disease: Molecular Mechanisms, Therapeutic Potential, and Future PerspectivesNachiket Joshi, Prachee Khadse, Shivani Jadhav, et al.
Chemistry & Biodiversity|September 11, 2025
Multi-Target Approach for Drug-Resistant Epilepsy: An In Silico Exploration of Promising PhytochemicalsNidhi Khedpande, Nachiket Joshi, RajaSekhar Reddy Alavala, et al.
Computational Biology and Chemistry|March 20, 2024
In silico exploration of CB2 receptor agonist in the management of neuroinflammatory conditions by pharmacophore modelingShlok Bodke, Nachiket Joshi, Rajasekhar Reddy Alavala, et al.
South Asian Journal of Cancer|March 10, 2025
Real-World Evidence for Comparative Outcomes between Innovator and Biosimilar Bevacizumab in Advanced Colorectal CancersArvind Vaidyanathan, Pranaya Vana, Nachiket Joshi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Molecular Diversity|January 24, 2024
Sulfonamido, amido heterocyclic adducts of tetrazole derivatives as BACE1 inhibitors: in silico explorationNachiket Joshi, Rajasekhar Reddy Alavala
Computational Biology and Chemistry|April 29, 2025
Identification of novel ligands against GSK-3β: Molecular docking, ADMET filtering, MD simulations, MM-GBSA studies, and DFT analysisNachiket Joshi, RajaSekhar Reddy Alavala
Chemistry & Biodiversity|January 24, 2025
Acetohydroxyacid Synthase (AHAS) Inhibitors as Antitubercular Agents: Insights From Molecular Docking and Dynamics SimulationsKunal Gokhale, Nachiket Joshi, RajaSekhar Reddy Alavala
Chirurgia (Bucharest, Romania : 1990)|May 25, 2026
Laparoscopic Surgery: Patient Benefits and Surgeon Challenges. A Systematic Literature Review and Narrative SynthesisAaliyah Abimbola, Gabriella Quiney, Nachiket Joshi, et al.
Current Topics in Medicinal Chemistry|June 18, 2025
Histone Deacetylase Inhibition in Alzheimer's Disease: Molecular Mechanisms, Therapeutic Potential, and Future PerspectivesNachiket Joshi, Prachee Khadse, Shivani Jadhav, et al.
Chemistry & Biodiversity|September 11, 2025
Multi-Target Approach for Drug-Resistant Epilepsy: An In Silico Exploration of Promising PhytochemicalsNidhi Khedpande, Nachiket Joshi, RajaSekhar Reddy Alavala, et al.
Computational Biology and Chemistry|March 20, 2024
In silico exploration of CB2 receptor agonist in the management of neuroinflammatory conditions by pharmacophore modelingShlok Bodke, Nachiket Joshi, Rajasekhar Reddy Alavala, et al.
South Asian Journal of Cancer|March 10, 2025
Real-World Evidence for Comparative Outcomes between Innovator and Biosimilar Bevacizumab in Advanced Colorectal CancersArvind Vaidyanathan, Pranaya Vana, Nachiket Joshi, et al.
Pageof 1